THE INTERPLAY OF LEARNING AND ANXIETY IN THE ELEVATED PLUS-MAZE

被引:269
作者
FILE, SE
机构
[1] Psychopharmacology Research Unit, UMDS Division of Pharmacology, Guy's Hospital, London
关键词
GENERALIZED ANXIETY; PHOBIA; LEARNING; BENZODIAZEPINES;
D O I
10.1016/0166-4328(93)90103-W
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
In naive rats benzodiazepines have clear anxiolytic effects in the elevated plus-maze, but in rats with previous plus-maze experience benzodiazepines are ineffective. This phenomenon does not depend on the drug state on trial 1 or on the inter-trial interval and generalises across mazes of different material; it is dependent on experience of the open arm. The phenomenon of ''one-trial tolerance'' to the anxiolytic effect of benzodiazepines is not seen in other animal tests; and there is no equivalent phenomenon of ''one-trial withdrawal'' or of tolerance to anxiogenic effects in the plus-maze. The phenomenon is not seen in unhandled rats, in rats given longer trials in the plus-maze, or in those given an amnesic treatment on trial 1. It is suggested that during the first 5 min in the elevated plus-maze the rats are acquiring a fear of heights and it is this phobic anxiety state that is measured during the second 5-min trial. Thus the nature of the anxiety generated by the maze is different on trials 1 and 2. The results of a factor analysis study confirm this conclusion.
引用
收藏
页码:199 / 202
页数:4
相关论文
共 25 条
  • [1] EARLY LIFE PROTEIN-MALNUTRITION CHANGES EXPLORATION OF THE ELEVATED PLUS-MAZE AND REACTIVITY TO ANXIOLYTICS
    ALMEIDA, SS
    DEOLIVEIRA, LM
    GRAEFF, FG
    [J]. PSYCHOPHARMACOLOGY, 1991, 103 (04) : 513 - 518
  • [2] ACUTE HANDLING STRESS DOWN-REGULATES BENZODIAZEPINE RECEPTORS - REVERSAL BY DIAZEPAM
    ANDREWS, N
    ZHARKOVSKY, A
    FILE, SE
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 210 (03) : 247 - 251
  • [3] ANDREWS N, 1991, BRIT J PHARMACOL, V103, pP305
  • [4] GABAERGIC AND DOPAMINERGIC TRANSMISSION IN THE RAT CEREBRAL-CORTEX - EFFECT OF STRESS, ANXIOLYTIC AND ANXIOGENIC DRUGS
    BIGGIO, G
    CONCAS, A
    CORDA, MG
    GIORGI, O
    SANNA, E
    SERRA, M
    [J]. PHARMACOLOGY & THERAPEUTICS, 1990, 48 (02) : 121 - 142
  • [5] BIGGIO G, 1983, BENZODIAZEPINE RECOG, P105
  • [6] ANIMAL-MODELS OF ANXIETY - THE EFFECT OF COMPOUNDS THAT MODIFY 5-HT NEUROTRANSMISSION
    CHOPIN, P
    BRILEY, M
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1987, 8 (10) : 383 - 388
  • [7] CRITCHLEY MAE, 1987, PSYCHOPHARMACOLOGY, V93, P502
  • [8] Davis M., 1991, PSYCHOPHARMACOLOGY A, P187
  • [9] MODIFICATION OF CHLORDIAZEPOXIDES BEHAVIORAL AND NEUROCHEMICAL EFFECTS BY HANDLING AND PLUS-MAZE EXPERIENCE
    FILE, SE
    ANDREWS, N
    WU, PY
    ZHARKOVSKY, A
    ZANGROSSI, H
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 218 (01) : 9 - 14
  • [10] CHARACTERIZATION OF THE PHENOMENON OF ONE-TRIAL TOLERANCE TO THE ANXIOLYTIC EFFECT OF CHLORDIAZEPOXIDE IN THE ELEVATED PLUS-MAZE
    FILE, SE
    MABBUTT, PS
    HITCHCOTT, PK
    [J]. PSYCHOPHARMACOLOGY, 1990, 102 (01) : 98 - 101